Insider · CIK 0001038704

LEBEL FRANCOIS

Reports to the SEC for 2 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001038704

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-23	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−6,667 sh	$0.84	−$5,593.613	644,790
2022-06-22	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−6,096 sh	$0.81	−$4,913.376	651,457
2022-06-21	SPECTRUM PHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+405K sh	—	—	657,553
2022-06-21	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+1.49M sh	—	—	1,488,940
2022-04-05	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,367 sh	$1.41	−$1,927.47	252,513
2022-04-04	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,205 sh	$1.35	−$1,626.75	253,880
2022-03-16	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−25.1K sh	$0.71	−$17.7K	255,085
2022-03-15	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−25.1K sh	$0.70	−$17.7K	280,190
2022-02-24	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−14.7K sh	$0.64	−$9,413.12	305,320
2022-02-23	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−13.5K sh	$0.70	−$9,466.598	320,028
2021-11-09	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−6,000 sh	$2.18	−$13.1K	329,166
2021-11-08	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−7,363 sh	$2.20	−$16.2K	335,166
2021-06-23	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−5,000 sh	$4.00	−$20K	340,046
2021-06-22	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−5,821 sh	$4.09	−$23.8K	345,046
2021-04-06	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,025 sh	$3.24	−$3,321	350,867
2021-04-05	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,125 sh	$3.31	−$3,726	351,892
2021-03-16	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−18.8K sh	$3.69	−$69.5K	353,017
2021-03-15	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−22.6K sh	$3.63	−$82K	371,845
2021-02-18	SPECTRUM PHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+110K sh	—	—	418,526
2021-02-18	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+134K sh	—	—	133,708
2021-02-18	SPECTRUM PHARMACEUTICALS INCStock Appreciation RightA Award	Chief Medical Officer	AAward	+314K sh	—	—	314,213
2020-11-09	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−5,000 sh	$3.56	−$17.8K	306,424
2020-11-06	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−7,025 sh	$3.50	−$24.6K	301,424
2020-06-23	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−4,167 sh	$3.35	−$14K	292,729
2020-06-22	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−5,474 sh	$3.16	−$17.3K	296,896
2020-04-03	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−854 sh	$2.18	−$1,861.72	302,370
2020-04-02	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−1,228 sh	$2.17	−$2,667.216	303,224
2020-03-12	SPECTRUM PHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+188K sh	—	—	304,452
2020-03-12	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+300K sh	—	—	300,000
2020-03-12	SPECTRUM PHARMACEUTICALS INCStock Appreciation RightA Award	Chief Medical Officer	AAward	+250K sh	—	—	250,000
2019-11-06	SPECTRUM PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−6,963 sh	$8.16	−$56.8K	113,970
2019-06-19	SPECTRUM PHARMACEUTICALS INCA Award	Chief Medical Officer	AAward	+50K sh	—	—	120,250
2019-06-19	SPECTRUM PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+125K sh	—	—	50,000
2017-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Executive Vice President R&D	FTax Payment	−21.7K sh	$4.14	−$89.7K	200,566
2017-12-30	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Executive Vice President R&D	FTax Payment	−31.5K sh	$4.14	−$130K	222,233
2017-12-29	TCRTAlaunos Therapeutics, Inc.A Award	Executive Vice President R&D	AAward	+116K sh	—	—	253,683
2016-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Executive Vice President R&D	FTax Payment	−21.7K sh	$5.35	−$116K	137,683
2016-12-30	TCRTAlaunos Therapeutics, Inc.A Award	Executive Vice President R&D	AAward	+94.4K sh	—	—	159,350
2015-12-31	TCRTAlaunos Therapeutics, Inc.A Award	Executive Vice President R&D	AAward	+65K sh	—	—	65,000
2015-06-09	TCRTAlaunos Therapeutics, Inc.M Exercise/Conversion	Executive Vice President R&D	MExercise/Conversion	+50K sh	$4.34	+$217K	50,000
2015-06-09	TCRTAlaunos Therapeutics, Inc.S Sale	Executive Vice President R&D	SSale	−50K sh	$10.12	−$506K	0
2015-06-09	TCRTAlaunos Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Executive Vice President R&D	MExercise/Conversion	−50K sh	—	—	100,000

Recent filings

Accepted (ET)
Jun 234
LEBEL FRANCOIS0001209191-22-039063
SEC(opens sec.gov)
Apr 54
LEBEL FRANCOIS0001209191-22-023224
SEC(opens sec.gov)
Mar 164
LEBEL FRANCOIS0001209191-22-019341
SEC(opens sec.gov)
Feb 244
LEBEL FRANCOIS0001209191-22-012928
SEC(opens sec.gov)
Nov 104
LEBEL FRANCOIS0001209191-21-064002
SEC(opens sec.gov)
Jun 234
LEBEL FRANCOIS0001209191-21-042775
SEC(opens sec.gov)
Apr 64
LEBEL FRANCOIS0001209191-21-025722
SEC(opens sec.gov)
Mar 174
LEBEL FRANCOIS0001209191-21-021497
SEC(opens sec.gov)
Feb 244
LEBEL FRANCOIS0001209191-21-013884
SEC(opens sec.gov)

Companies

Address

C/O ZIOPHARM ONCOLOGY, INC., NAVY YARD ONE FIRST AVE., BLDG #34

BOSTON, MA, 02129